Trevi Therapeutics Appoints New Chief Financial Officer

TradingView
2025.12.05 14:05
portai
I'm PortAI, I can summarize articles.

On December 4, 2025, Trevi Therapeutics, Inc. announced the appointment of David Hastings as the new Chief Financial Officer, effective January 6, 2026.IndividualDavid HastingsRoleChief Financial OfficerType of ChangeAppointedEffective DateJanuary 6, 2026ReasonNot disclosedReplacement InfoN/ABackground DetailsFormer CFO of Arbutus Biopharma, Unilife, Incyte, and ArQuleBoard/Committee Role ChangesNot disclosedOriginal SEC Filing: Trevi Therapeutics, Inc. [ TRVI ] - 8-K - Dec. 05, 2025DisclaimerThis is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.

Source: TradingView The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
© 2025 Longbridge｜Disclaimer